Stock Track | Recursion Pharmaceuticals Soars 12.63% Pre-market on Nvidia's Sustained Investment

Stock Track

Feb 18, 2025

Recursion Pharmaceuticals, Inc. (RXRX) stock surged 12.63% in the pre-market trading session on Tuesday, following Nvidia's disclosure that it maintained its investment in the medical AI company during the fourth quarter of 2024.

According to regulatory filings, Nvidia revealed that it held on to its stake in Recursion Pharmaceuticals, a move that has bolstered investor confidence in the company's prospects. This sustained backing from the tech giant has fueled the pre-market rally, as traders view Nvidia's continued investment as a vote of confidence in Recursion Pharmaceuticals' potential.

The positive sentiment surrounding Recursion Pharmaceuticals was further amplified by Berkshire Hathaway's recent investment activities, including taking a new position in Constellation Brands, a move that has injected optimism into the broader market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1169264149"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1169264149\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1169264149?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-18 17:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169264149","market":"hk","top_or_hot":-1,"title":"Stock Track | Recursion Pharmaceuticals Soars 12.63% Pre-market on Nvidia's Sustained Investment","media":"Stock Track","content":"<p>Recursion Pharmaceuticals, Inc. (RXRX) stock surged 12.63% in the pre-market trading session on Tuesday, following Nvidia's disclosure that it maintained its investment in the medical AI company during the fourth quarter of 2024.</p>\n\n<p>According to regulatory filings, Nvidia revealed that it held on to its stake in Recursion Pharmaceuticals, a move that has bolstered investor confidence in the company's prospects. This sustained backing from the tech giant has fueled the pre-market rally, as traders view Nvidia's continued investment as a vote of confidence in Recursion Pharmaceuticals' potential.</p>\n\n<p>The positive sentiment surrounding Recursion Pharmaceuticals was further amplified by Berkshire Hathaway's recent investment activities, including taking a new position in Constellation Brands, a move that has injected optimism into the broader market.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Recursion Pharmaceuticals Soars 12.63% Pre-market on Nvidia's Sustained Investment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Recursion Pharmaceuticals Soars 12.63% Pre-market on Nvidia's Sustained Investment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-18 17:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Recursion Pharmaceuticals, Inc. (RXRX) stock surged 12.63% in the pre-market trading session on Tuesday, following Nvidia's disclosure that it maintained its investment in the medical AI company during the fourth quarter of 2024.</p>\n\n<p>According to regulatory filings, Nvidia revealed that it held on to its stake in Recursion Pharmaceuticals, a move that has bolstered investor confidence in the company's prospects. This sustained backing from the tech giant has fueled the pre-market rally, as traders view Nvidia's continued investment as a vote of confidence in Recursion Pharmaceuticals' potential.</p>\n\n<p>The positive sentiment surrounding Recursion Pharmaceuticals was further amplified by Berkshire Hathaway's recent investment activities, including taking a new position in Constellation Brands, a move that has injected optimism into the broader market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RXRX","symbol_name":"Recursion Pharmaceuticals, Inc.","start_time":0,"source_url":"","article_id":"1169264149","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169264149","pubTimestamp":1739872217,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Recursion Pharmaceuticals, Inc.  stock surged 12.63% in the pre-market trading session on Tuesday, following Nvidia's disclosure that it maintained its investment in the medical AI company during the fourth quarter of 2024.According to regulatory filings, Nvidia revealed that it held on to its stake in Recursion Pharmaceuticals, a move that has bolstered investor confidence in the company's prospects. This sustained backing from the tech giant has fueled the pre-market rally, as traders view Nvi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RXRX":"Recursion Pharmaceuticals, Inc."},"translate_title":"股票赛道Recursion Pharmaceuticals盘前飙升12.63%因英伟达持续投资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RXRX":1},"content_text":"Recursion Pharmaceuticals, Inc. (RXRX) stock surged 12.63% in the pre-market trading session on Tuesday, following Nvidia's disclosure that it maintained its investment in the medical AI company during the fourth quarter of 2024.\nAccording to regulatory filings, Nvidia revealed that it held on to its stake in Recursion Pharmaceuticals, a move that has bolstered investor confidence in the company's prospects. This sustained backing from the tech giant has fueled the pre-market rally, as traders view Nvidia's continued investment as a vote of confidence in Recursion Pharmaceuticals' potential.\nThe positive sentiment surrounding Recursion Pharmaceuticals was further amplified by Berkshire Hathaway's recent investment activities, including taking a new position in Constellation Brands, a move that has injected optimism into the broader market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}